Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other Non-Current Assets (2018 - 2025)

TransMedics has reported Other Non-Current Assets over the past 8 years, most recently at $500000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $500000.0 for Q4 2025, up 140.38% from a year ago — trailing twelve months through Dec 2025 was $500000.0 (up 140.38% YoY), and the annual figure for FY2025 was $500000.0, up 140.38%.
  • Other Non-Current Assets for Q4 2025 was $500000.0 at TransMedics, up from $226000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for TMDX hit a ceiling of $750000.0 in Q1 2023 and a floor of $60000.0 in Q3 2023.
  • Median Other Non-Current Assets over the past 5 years was $500000.0 (2021), compared with a mean of $439950.0.
  • Biggest five-year swings in Other Non-Current Assets: soared 8233.33% in 2021 and later tumbled 88.8% in 2024.
  • TransMedics' Other Non-Current Assets stood at $500000.0 in 2021, then changed by 0.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then plummeted by 58.4% to $208000.0 in 2024, then surged by 140.38% to $500000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $500000.0 (Q4 2025), $226000.0 (Q3 2025), and $221000.0 (Q2 2025) per Business Quant data.